Clinical trial
CHemotherapy Plus Enzalutamide In First Line Therapy for Castration Resistant prOstate caNcer
NCT02453009 is registered in ClinicalTrials.gov with Santa Chiara Hospital as lead sponsor.
Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Registry record
As filed in ClinicalTrials.gov.
- Title
- CHemotherapy Plus Enzalutamide In First Line Therapy for Castration Resistant prOstate caNcer
- Lead sponsor
- Santa Chiara Hospital
- Phase
- Phase 2
- Overall status
- Completed
- Start date
- October 31, 2014
- Completion date
- April 30, 2019
- Enrollment
- 246 (actual)
- Sites
- 1
Conditions
As the registry lists them; a condition with its own page is linked.